Study of Urate Elevation in Parkinson's Disease, Phase 3
A Randomized, Double-blind, Placebo-controlled Trial of Urate-elevating Inosine Treatment to Slow Clinical Decline in Early Parkinson's Disease A Randomized, Double-blind, Placebo-controlled Trial of Urate-elevating Inosine Treatment to Slow Cl ...
Parkinson's Disease
Drug: Inosine;Drug: Placebo
Michael Alan Schwarzschild
The Parkinson Study Group;Michael J. Fox Foundation for Parkinson's Research;University of Rochester;National Institute of Neurological Disorders and Stroke (NINDS) The Parkinson Study Group;Michael J. Fox Foundation for Parkinson's Research;University of Rochester ...
Randomized clinical trial to assess the disease modifying effect of oral inosine for patients with Parkinson's disease Randomized clinical trial to assess the disease modifying effect of oral inosine for patients with P ...
Multi-centered, placebo-controlled, double-blind, randomized clinical trial to assess the effect of oral inosine on the onset of wearing off in patients with early stage Parkinson's disease - Multi-centered, placebo-controlled, double-blind, randomized clinical trial to assess the effect of oral inosine on the onset of wearing off in patients with early stage Parkinson's disease Multi-centered, placebo-controlled, double-blind, randomized clinical trial to assess the effect of ...
Parkinson's disease;D010300
Inosine to maintain a serum urate level between 6.0-7.5 mg/dL for 2 years or placebo (500mg/CP)
Multi-centered, placebo-controlled, double-blind, randomized clinical trial to assess the effect of oral inosine on the onset of wearing off in patients with early stage Parkinson's disease Multi-centered, placebo-controlled, double-blind, randomized clinical trial to assess the effect of ...
Multi-centered, placebo-controlled, double-blind, randomized clinical trial to assess the effect of oral inosine on the onset of wearing off in patients with early stage Parkinson's disease - Randomized clinical trial to assess the disease modifying effect of oral inosine for patients with Parkinson's disease Multi-centered, placebo-controlled, double-blind, randomized clinical trial to assess the effect of ...
Parkinson's disease
Inosine to maintain a serum urate level between 6.0-7.5 mg/dL for 2 years Lactose as a placebo for 2 years Inosine to maintain a serum uratelevel between 6.0-7.5 mg/dL for 2 years Lactose as a placebo for 2 y ...
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety ...
Parkinson Disease
Drug: Placebo;Drug: inosine
The Parkinson Study Group
Massachusetts General Hospital;Harvard School of Public Health;University of Rochester;Michael J. Fox Foundation for Parkinson's Research Massachusetts General Hospital;Harvard School of Public Health;University of Rochester;Michael J. Fo ...